MLANA and metastatic melanoma: TILs from an HLA-A2+ metastatic melanoma patient were incubated with brefeldin A and monensin ± autologous tumor for 4 h prior to staining with Melan A tetramer and intracellularly with anti–IFN-γ Ab (Fig. 7A).